HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biospecific haemosorbents based on proteinase inhibitor. II. Efficiency of biospecific antiproteinase haemosorbent 'Ovosorb' in complex treatment of experimental generalized purulent peritonitis and acute destructive pancreatitis in dogs.

Abstract
The biospecific antiproteinase haemosorbent (BAH) 'Ovosorb' containing, in the bulk of polyacryamide gel, the ovomucoid from whites of duck eggs, was used for a complex treatment of the experimental generalized purulent peritonitis and acute destructive pancreatitis in dogs. The efficiency of BAH was manifested in the significant reduction of lethality of the experimental animals, a more rapid liquidation of proteinasaemia, normalization in plasma of alpha 1-proteinase inhibitor and protein metabolism. Thus, by eliminating proteinases from circulation, Ovosorb contributes to the cessation of imbalance in the proteinase-inhibitor system and is efficient in the therapy of pathological states related to this imbalance.
AuthorsN A Platé, V V Kirkovsky, O F Antiperovich, V V Nicolaichik, T A Valueva, S B Sinilo, V M Moin, G A Lobacheva
JournalBiomaterials (Biomaterials) Vol. 15 Issue 4 Pg. 285-8 (Mar 1994) ISSN: 0142-9612 [Print] Netherlands
PMID8031989 (Publication Type: Journal Article)
Chemical References
  • Protease Inhibitors
  • Ovosorb
  • Ovomucin
Topics
  • Acute Disease
  • Animals
  • Dogs
  • Ovomucin (therapeutic use)
  • Pancreatitis (drug therapy, metabolism)
  • Peritonitis (drug therapy, metabolism)
  • Protease Inhibitors (therapeutic use)
  • Suppuration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: